Cryptococcal Meningitis
📧 Sign up to get email alerts when something new happens for Cryptococcal Meningitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: Vietnam Cryptococcal Retention in Care Study (CRICS) Federal Financial Report [Phase 1]
Phase 1 CRICS trial in Vietnam involving cryptococcal meningitis has completed and a Federal Financial Report has been filed.
-
CLINICAL_TRIALS research · 2018-03-15Clinical Trial Update: Pre-Antiretroviral Therapy (ART) Cryptococcal Antigen Screening in AIDS [NA]
This clinical trial entry discusses a study assessing pre-antiretroviral therapy cryptococcal antigen screening to prevent cryptococcal meni…
-
CLINICAL_TRIALS trial_result · 2018-03-12Clinical Trial Update: High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals [Phase 1, Phase 2]
Clinical trial update on high-dose fluconazole for cryptococcal meningitis in HIV patients; phases 1/2 completed with results posted.
-
FDA approval · 2017-07-07FDA Approved: FLUCYTOSINE — Original Application (Lupin Pharmaceuticals,Inc.)
The FDA approved Lupin Pharmaceuticals' original application for Flucytosine (generic) to market the drug in the United States.
-
CLINICAL_TRIALS trial_result · 2016-07-18Clinical Trial Update: Early Versus Delayed Antiretroviral Therapy (ART) in the Treatment of Cryptococcal Meningitis in Africa [NA]
A completed clinical trial evaluating early versus delayed antiretroviral therapy in patients with cryptococcal meningitis and HIV infection…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-07-12Clinical Trial Update: Study Evaluating Efficiency and Tolerance of High-dose Fluconazole Associated With Flucytosine as Induction Therapy for Cryptococcal Meningitis Associated With HIV in Sub-saharan Africa [Phase 2, Phase 3]
This is an update on a Phase 2/3 clinical trial evaluating high-dose fluconazole in combination with flucytosine as induction therapy for cr…
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: Efficacy of Intrathecal Administration of Liposomal Amphotericin B in Cryptococcal Meningitis [Phase 4]
Phase 4 trial evaluating intrathecal liposomal amphotericin B for cryptococcal meningitis. Current status is unknown.
-
CLINICAL_TRIALS trial_result · 2016-01-18Clinical Trial Update: Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases in Neurological Disorders in DRC [Phase 3]
A Phase 3 clinical trial in the Democratic Republic of Congo evaluating rapid diagnostic tests and clinical/laboratory predictors for cerebr…
-
FDA approval · 2015-03-19FDA Approved: FLUCONAZOLE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Fluconazole from Hikma Pharmaceuticals USA Inc., updating the regulatory approval of this pr…
-
FDA approval · 2015-03-14FDA Approved: FLUCONAZOLE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for fluconazole from Glenmark Pharmaceuticals Inc., USA.
-
FDA approval · 2015-02-27FDA Approved: FLUCONAZOLE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for fluconazole from Rising Pharma Holdings, Inc. for a generic fluconazole product.
-
CLINICAL_TRIALS research · 2014-08-20Clinical Trial Update: Cryptococcal Optimal ART Timing Trial [Phase 4]
A Phase 4 trial evaluating the timing of antiretroviral therapy in cryptococcal meningitis with results posted in 2014.
-
CLINICAL_TRIALS research · 2014-05-12Clinical Trial Update: Liposomal Amphotericin B for the Treatment of Cryptococcal Meningitis [NA]
A clinical trial update discusses Liposomal Amphotericin B for treating cryptococcal meningitis, with no current status details available.
-
CLINICAL_TRIALS trial_result · 2014-03-28Clinical Trial Update: Clinical Outcomes of Cryptococcal Meningitis Among HIV-infected Patients in the Era of Antiretroviral Therapy
This is a completed clinical trial update on outcomes of cryptococcal meningitis in HIV-infected patients in the era of antiretroviral thera…
-
FDA approval · 2014-03-24FDA Approved: FLUCONAZOLE IN SODIUM CHLORIDE — Supplemental Application (Hospira, Inc.)
The FDA approved Hospira's supplemental application for Fluconazole in Sodium Chloride, an intravenous formulation of fluconazole.
-
FDA approval · 2014-01-07FDA Approved: DIFLUCAN — Supplemental Application (Roerig)
The FDA approved a Roerig supplemental application for DIFLUCAN (fluconazole).
-
FDA approval · 2012-03-14FDA Approved: FLUCONAZOLE — Supplemental Application (Hospira, Inc)
The FDA approved a supplemental application for fluconazole submitted by Hospira, Inc., authorizing changes to the product under the ANDA.
-
CLINICAL_TRIALS trial_result · 2012-02-07Clinical Trial Update: Optimal Time to Start Antiretroviral Therapy in HIV-infected Adults With Cryptococcal Meningitis [Phase 4]
This Phase 4 clinical trial update reports results on the optimal timing of starting antiretroviral therapy in adults with HIV infection and…
-
FDA approval · 2012-01-30FDA Approved: FLUCONAZOLE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approves Hikma Pharmaceuticals USA Inc.'s generic fluconazole under Original Application (ANDA 078698). The approval covers multiple fun…
-
FDA approval · 2012-01-30FDA Approved: FLUCONAZOLE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approves Hikma Pharmaceuticals USA Inc.'s original application for a generic fluconazole to treat fungal infections, including candidias…
-
FDA approval · 2012-01-25FDA Approved: FLUCONAZOLE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for fluconazole submitted by Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2011-10-13FDA Approved: FLUCONAZOLE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for fluconazole by Rising Pharma Holdings, Inc., authorizing an updated generic product under the AN…
-
FDA approval · 2011-06-28FDA Approved: FLUCYTOSINE — Original Application (Sigmapharm Laboratories, LLC)
FDA approved a generic version of Flucytosine from Sigmapharm Laboratories via an original ANDA.
-
CLINICAL_TRIALS trial_result · 2011-03-14Clinical Trial Update: Comparison of Fluconazole and Amphotericin B in the Treatment of Brain Infections in Patients With AIDS [Phase 3]
Phase 3 clinical trial comparing fluconazole to amphotericin B for the treatment of cryptococcal meningitis in patients with AIDS has comple…
-
CLINICAL_TRIALS trial_result · 2011-03-14Clinical Trial Update: Multi-center Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis [NA]
A multi-center trial comparing fluconazole and amphotericin B for acute cryptococcal meningitis in HIV-infected patients has completed.